Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases — Stella

Recruiting

Back to Melanoma Brain Metastases trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

Australia

Alfred Health, Melbourne, Victoria

Key details

Phase

First-in-human testing / Safety & dosing

Sponsor

Melanoma and Skin Cancer Trials Limited

Enrollment target

~46 participants

Started

May 2025

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov